Skip to main content
. 2010 Feb 10;10:39. doi: 10.1186/1471-2407-10-39

Table 5.

Three-year survival in the 346 patients with N+ disease treated with vs. without concurrent chemotherapy

No concurrent chemotherapy With concurrent chemotherapy P Value
MFS 82.5 83.7 0.50
DFS 79.3 81.7 0.66
OS 88.3 88.5 0.85